Lipidomics: Potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease

Pharmacology and Therapeutics

Volumn 143, Issue 1, 2014, Pages 12-23

  Meikle, Peter J ^a   Wong, Gerard ^a   Barlow, Christopher K ^a   Kingwell, Bronwyn A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Bioinformatics; Cardiovascular disease; Diabetes; Lipid metabolism; Risk assessment; Therapeutic monitoring

Indexed keywords

ATORVASTATIN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LIPOPROTEIN; METFORMIN; ROSUVASTATIN; SIMVASTATIN;

ARTICLE; BIOINFORMATICS; CARDIOVASCULAR DISEASE; DIET THERAPY; DYSLIPIDEMIA; HUMAN; LIFESTYLE MODIFICATION; LIPID METABOLISM; LIPIDOMICS; MEASUREMENT; MUSCLE DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; RISK ASSESSMENT; TECHNOLOGY; TREATMENT RESPONSE; ANIMAL; BIOLOGY; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; RISK; STATISTICAL ANALYSIS;

ANIMALS; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPUTATIONAL BIOLOGY; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, TYPE 2; HUMANS; LIPID METABOLISM; PRINCIPAL COMPONENT ANALYSIS; RISK; RISK ASSESSMENT;

EID: 84898891503     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2014.02.001     Document Type: Review

References (101)

1. A. Arbab-Zadeh, M. Nakano, R. Virmani, and V. Fuster Acute coronary events Circulation 125 2012 1147 1156
2. E.L. Barr, P.Z. Zimmet, T.A. Welborn, D. Jolley, D.J. Magliano, and D.W. Dunstan et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Circulation 116 2007 151 157 (Pubitemid 47057520)
3. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc Ser B Methodol 1995 289 300
4. S.C. Bergheanu, T. Reijmers, A.H. Zwinderman, I. Bobeldijk, R. Ramaker, and A.H. Liem et al. Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins Curr Med Res Opin 24 2008 2477 2487
5. A. Blazek, J. Rutsky, K. Osei, A. Maiseyeu, and S. Rajagopalan Exercise-mediated changes in high-density lipoprotein: impact on form and function Am Heart J 166 2013 392 400
6. J. Boon, A.J. Hoy, R. Stark, R.D. Brown, R.C. Meex, and D.C. Henstridge et al. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance Diabetes 62 2013 401 410
7. A.P. Burke, F.D. Kolodgie, A. Zieske, D.R. Fowler, D.K. Weber, and P.J. Varghese et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study Arterioscler Thromb Vasc Biol 24 2004 1266 1271 (Pubitemid 38880019)
8. E. Cassol, V. Misra, A. Holman, A. Kamat, S. Morgello, and D. Gabuzda Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors BMC Infect Dis 13 2013 203
9. D.H. Chace, and A.R. Spitzer Altered metabolism and newborn screening using tandem mass spectrometry: lessons learned from the bench to bedside Curr Pharm Biotechnol 12 2011 965 975
10. C. Chang, and C. Lin LIBSVM: a library for support vector machines ACM Trans Intel Syst Technol 2 2011 1 27
11. F. Chen, V. Maridakis, E.A. O'Neill, B.K. Hubbard, A. Strack, and C. Beals et al. The effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidaemia Biomarkers 16 2011 321 333
12. M.J. Davies Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995 Circulation 94 1996 2013 2020 (Pubitemid 26349317)
13. B. Davis, G. Koster, L.J. Douet, M. Scigelova, G. Woffendin, and J.M. Ward et al. Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein J Biol Chem 283 2008 6428 6437
14. V.D. de Mello, M. Lankinen, U. Schwab, M. Kolehmainen, S. Lehto, and T. Seppanen-Laakso et al. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease Diabetologia 52 2009 2612 2615
15. S. Dzeletovic, O. Breuer, E. Lund, and U. Diczfalusy Determination of cholesterol oxidation products in Human Plasma by Isotope Dilution-Mass Spectrometry Anal Chem 225 1995 73 80
16. C.S. Ejsing, E. Duchoslav, J. Sampaio, K. Simons, R. Bonner, and C. Thiele et al. Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning Anal Chem 78 2006 6202 6214 (Pubitemid 44360134)
17. K. Ekroos, I.V. Chernushevich, K. Simons, and A. Shevchenko Quantitative profiling of phospholipids by multiple precursor ion scanning on a hybrid quadrupole time-of-flight mass spectrometer Anal Chem 74 2002 941 949 (Pubitemid 34203015)
18. C.V. Felton, D. Crook, M.J. Davies, and M.F. Oliver Relation of plaque lipid composition and morphology to the stability of human aortic plaques Arterioscler Thromb Vasc Biol 17 1997 1337 1345 (Pubitemid 27329858)
19. K. Gertow, E. Nobili, L. Folkersen, J.W. Newman, T.L. Pedersen, and J. Ekstrand et al. 12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms Atherosclerosis 215 2011 411 416
20. I.J. Goldberg Clinical review 124: Diabetic dyslipidemia: causes and consequences J Clin Endocrinol Metab 86 2001 965 971 (Pubitemid 32322966)
21. N. Goto-Inoue, K. Yamada, A. Inagaki, Y. Furuichi, S. Ogino, and Y. Manabe et al. Lipidomics analysis revealed the phospholipid compositional changes in muscle by chronic exercise and high-fat diet Sci Rep 3 2013 3267
22. I. Guyon, J. Weston, S. Barnhill, and V. Vapnik Gene selection for cancer classification using support vector machines Mach Learn 46 2002 389 422 (Pubitemid 34129977)
23. L.D. Han, J.F. Xia, Q.L. Liang, Y. Wang, Y.M. Wang, and P. Hu et al. Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy Anal Chim Acta 689 2011 85 91
24. X. Han, and R.W. Gross Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples Mass Spectrom Rev 24 2005 367 412 (Pubitemid 40665798)
25. X. Han, K. Yang, H. Cheng, K.N. Fikes, and R.W. Gross Shotgun lipidomics of phosphoethanolamine-containing lipids in biological samples after one-step in situ derivatization J Lipid Res 46 2005 1548 1560 (Pubitemid 43109820)
26. X. Han, K. Yang, and R.W. Gross Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses Mass Spectrom Rev 31 2012 134 178
27. X. Han, K. Yang, J. Yang, K.N. Fikes, H. Cheng, and R.W. Gross Factors influencing the electrospray intrasource separation and selective ionization of glycerophospholipids J Am Soc Mass Spectrom 17 2006 264 274 (Pubitemid 43185252)
28. J.M. Haus, S.R. Kashyap, T. Kasumov, R. Zhang, K.R. Kelly, and R.A. Defronzo et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance Diabetes 58 2009 337 343
29. L.K. Heilbronn, A.C. Coster, L.V. Campbell, J.R. Greenfield, K. Lange, and M.J. Christopher et al. The effect of short-term overfeeding on serum lipids in healthy humans Obesity (Silver Spring) 21 2013 E649 E659
30. A. Hiukka, M. Stahlman, C. Pettersson, M. Levin, M. Adiels, and S. Teneberg et al. ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan Diabetes 58 2009 2018 2026
31. C. Hu, M. Hoene, X. Zhao, H.U. Haring, E. Schleicher, and R. Lehmann et al. Lipidomics analysis reveals efficient storage of hepatic triacylglycerides enriched in unsaturated fatty acids after one bout of exercise in mice PLoS ONE 5 2010 e13318
32. G. Hughes, C. Cruickshank-Quinn, R. Reisdorph, S. Lutz, I. Petrache, and N. Reisdorph et al. MSPrep - Summarization, normalization and diagnostics for processing of mass spectrometry-based metabolomic data Bioinformatics 30 2014 133 134
33. T. Huo, S. Cai, X. Lu, Y. Sha, M. Yu, and F. Li Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride J Pharm Biomed Anal 49 2009 976 982
34. P.M. Hutchins, E.E. Moore, and R.C. Murphy Electrospray MS/MS reveals extensive and nonspecific oxidation of cholesterol esters in human peripheral vascular lesions J Lipid Res 52 2011 2070 2083
35. S. Inaba, H. Okayama, J. Funada, H. Higashi, M. Saito, and T. Yoshii et al. Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis Eur Heart J Cardiovasc Imaging 13 2012 717 723
36. J.W. Jukema, A.H. Liem, P.H. Dunselman, J.A. van der Sloot, D.J. Lok, and A.H. Zwinderman LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages and Reverse cholesterol transport) study Curr Med Res Opin 21 2005 1865 1874 (Pubitemid 41667255)
37. R. Kaddurah-Daouk, R.A. Baillie, H. Zhu, Z.B. Zeng, M.M. Wiest, and U.T. Nguyen et al. Lipidomic analysis of variation in response to simvastatin in the cholesterol and pharmacogenetics study Metabolomics 6 2010 191 201
38. M. Katajamaa, J. Miettinen, and M. Orešič MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data Bioinformatics 22 2006 634 636 (Pubitemid 43372832)
39. A. Keech, R.J. Simes, P. Barter, J. Best, R. Scott, and M.R. Taskinen et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial Lancet 366 2005 1849 1861
40. D. Kirpichnikov, S.I. McFarlane, and J.R. Sowers Metformin: an update Ann Intern Med 137 2002 25 33 (Pubitemid 34705373)
41. M. Kolehmainen, T. Salopuro, U.S. Schwab, J. Kekalainen, P. Kallio, and D.E. Laaksonen et al. Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study Int J Obes 32 2008 292 303 (Pubitemid 351271783)
42. I. Kononenko, E. Simec, and M. Robnik-Sikonja Overcoming the myopia of inductive learning algorithms with RELIEFF Appl Intell 7 1997 39 55 (Pubitemid 127508778)
43. A. Kontush, S. Chantepie, and M.J. Chapman Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress Arterioscler Thromb Vasc Biol 23 2003 1881 1888 (Pubitemid 37254879)
44. A. Kontush, and M.J. Chapman Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities Curr Opin Lipidol 21 2010 312 318
45. A. Kontush, P. Therond, A. Zerrad, M. Couturier, A. Negre-Salvayre, and J.A. de Souza et al. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities Arterioscler Thromb Vasc Biol 27 2007 1843 1849 (Pubitemid 47207181)
46. A. Kotronen, V.R. Velagapudi, L. Yetukuri, J. Westerbacka, R. Bergholm, and K. Ekroos et al. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations Diabetologia 52 2009 684 690
47. R. Laaksonen, M.T. Janis, and M. Oresic Lipidomics-based safety biomarkers for lipid-lowering treatments Angiology 59 2008 65S 68S
48. R. Laaksonen, M. Katajamaa, H. Paiva, M. Sysi-Aho, L. Saarinen, and P. Junni et al. A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle PLoS ONE 1 2006 e97
49. M. Lankinen, U. Schwab, A. Erkkila, T. Seppanen-Laakso, M.L. Hannila, and H. Mussalo et al. Fatty fish intake decreases lipids related to inflammation and insulin signaling - a lipidomics approach PLoS ONE 4 2009 e5258
50. X. Li, X. Luo, X. Lu, J. Duan, and G. Xu Metabolomics study of diabetic retinopathy using gas chromatography-mass spectrometry: a comparison of stages and subtypes diagnosed by Western and Chinese medicine Mol Biosyst 7 2011 2228 2237
51. J.B. Lindsey, J.A. House, K.F. Kennedy, and S.P. Marso Diabetes duration is associated with increased thin-cap fibroatheroma detected by intravascular ultrasound with virtual histology Circulation. Cardiovascular Interventions 2 2009 543 548
52. L. Lofgren, M. Stahlman, G.B. Forsberg, S. Saarinen, R. Nilsson, and G.I. Hansson The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma J Lipid Res 53 2012 1690 1700
53. A. Lommen, and H.J. Kools MetAlign 3.0: performance enhancement by efficient use of advances in computer hardware Metabolomics 8 2012 719 726
54. S.P. Marso, N. Mercado, A. Maehara, G. Weisz, G.S. Mintz, and J. McPherson et al. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes JACC Cardiovasc Imaging 5 2012 S42 S52
55. S. Mas, R. Martínez-Pinna, J.L. Martín-Ventura, R. Pérez, D. Gomez-Garre, and A. Ortiz et al. Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes Diabetes 59 2010 1292 1301
56. V. Matyash, G. Liebisch, T.V. Kurzchalia, A. Shevchenko, and D. Schwudke Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics J Lipid Res 49 2008 1137 1146
57. P.J. Meikle, G. Wong, C.K. Barlow, J.M. Weir, M.A. Greeve, and G.L. Macintosh et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes PLoS ONE 8 2013 e74341
58. P.J. Meikle, G. Wong, D. Tsorotes, C.K. Barlow, J.M. Weir, and M.J. Christopher et al. Plasma lipidomic analysis of stable and unstable coronary artery disease Arterioscler Thromb Vasc Biol 31 2011 2723 2732
59. V.D.F. Mello, M. Lankinen, U. Schwab, M. Kolehmainen, S. Lehto, and T. Seppänen-Laakso et al. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease Diabetologia 52 2009 2612 2615
60. M. Messner, C. Albert, J. McHowat, and D. Ford Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions Lipids 43 2008 243 249
61. T.W. Mitchell, N. Turner, P.L. Else, A.J. Hulbert, J.A. Hawley, and J.S. Lee et al. The effect of exercise on the skeletal muscle phospholipidome of rats fed a high-fat diet Int J Mol Sci 11 2010 3954 3964
62. S. Mora Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use Circulation 119 2009 2396 2404
63. P.J. Nestel, N. Straznicky, N.A. Mellett, G. Wong, D.P. De Souza, and D.L. Tull et al. Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity Am J Clin Nutr 99 2013 46 53
64. T.W. Ng, A.A. Kahn, and P.J. Meikle Investigating the pathogenesis and risk of Type 2 diabetes: clinical applications of metabolomics Clinical Lipidology 7 2012 641 659
65. T.W. Ng, G.F. Watts, P.H. Barrett, K.A. Rye, and D.C. Chan Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels Diabetes Care 30 2007 2945 2950 (Pubitemid 350083149)
66. M. Noakes, and P.M. Clifton Changes in plasma lipids and other cardiovascular risk factors during 3 energy-restricted diets differing in total fat and fatty acid composition Am J Clin Nutr 71 2000 706 712 (Pubitemid 30118562)
67. H. Nygren, T. Seppänen-Laakso, S. Castillo, T. Hyötylä inen, and M. Orešič Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues T.O. Metz, Metabolic Profiling Vol. 708 2011 Humana Press 247 257
68. D.S. Ong, J.J. Anzinger, F.J. Leyva, N. Rubin, L. Addadi, and H.S. Kruth Extracellular cholesterol-rich microdomains generated by human macrophages and their potential function in reverse cholesterol transport J Lipid Res 51 2010 2303 2313
69. M. Orešič, V.A. Hänninen, and A. Vidal-Puig Lipidomics: a new window to biomedical frontiers Trends Biotechnol 26 2008 647 652
70. J.D. Otvos, E.J. Jeyarajah, and D.W. Bennett Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy Clin Chem 37 1991 377 386 (Pubitemid 21892658)
71. J.D. Otvos, E.J. Jeyarajah, D.W. Bennett, and R.M. Krauss Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement Clin Chem 38 1992 1632 1638
72. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 (discussion 207-112) (Pubitemid 351193639)
73. C. Pettinella, S.H. Lee, F. Cipollone, and I.A. Blair Targeted quantitative analysis of fatty acids in atherosclerotic plaques by high sensitivity liquid chromatography/tandem mass spectrometry J Chromatogr B 850 2007 168 176 (Pubitemid 46618162)
74. K.H. Pietilainen, M. Sysi-Aho, A. Rissanen, T. Seppanen-Laakso, H. Yki-Jarvinen, and J. Kaprio et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects - a monozygotic twin study PLoS ONE 2 2007 e218
75. T. Pluskal, S. Castillo, A. Villar-Briones, and M. Orešič MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data BMC Bioinformatics 11 2010 395
76. E.A. Podrez, T.V. Byzova, M. Febbraio, R.G. Salomon, Y. Ma, and M. Valiyaveettil et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype Nat Med 13 2007 1086 1095 (Pubitemid 47517507)
77. E.A. Podrez, E. Poliakov, Z. Shen, R. Zhang, Y. Deng, and M. Sun et al. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions J Biol Chem 277 2002 38517 38523 (Pubitemid 35154710)
78. A.A. Rasmiena, T.W. Ng, and P.J. Meikle Metabolomics and ischaemic heart disease Clin Sci (Lond) 124 2013 289 306
79. J.T. Salonen, K. Nyyssonen, R. Salonen, E. Porkkala-Sarataho, T.-P. Tuomainen, and U. Diczfalusy et al. Lipoprotein oxidation and progression of carotid atherosclerosis Circulation 95 1997 840 845 (Pubitemid 27091523)
80. U. Schwab, T. Seppanen-Laakso, L. Yetukuri, J. Agren, M. Kolehmainen, and D.E. Laaksonen et al. Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism - the GENOBIN study PLoS ONE 3 2008 e2630
81. D. Schwudke, G. Liebisch, R. Herzog, G. Schmitz, and A. Shevchenko Shotgun lipidomics by tandem mass spectrometry under data-dependent acquisition control H.A. Brown, Methods in Enzymology Vol. 433 2007 Academic Press 175 191
82. J.A. Shaw, A.J. White, R. Reddy, S.J. Duffy, A.S. Walton, and B.A. Kingwell et al. Evaluation of differences in coronary plaque mechanical behavior in individuals with and without type 2 diabetes mellitus Arterioscler Thromb Vasc Biol 26 2006 2826 2827
83. J.A. Simon, F. Lin, S.B. Hulley, P.J. Blanche, D. Waters, and S. Shiboski et al. Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study Am J Cardiol 97 2006 843 850
84. B. Simons, D. Kauhanen, T. Sylvänne, K. Tarasov, E. Duchoslav, and K. Ekroos Shotgun lipidomics by sequential precursor ion fragmentation on a hybrid quadrupole time-of-flight mass spectrometer Metabolites 2 2012 195 213
85. C.A. Smith, E.J. Want, G. O'Maille, R. Abagyan, and G. Siuzdak XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification Anal Chem 78 2006 779 787 (Pubitemid 43228585)
86. M. Stahlman, J. Borén, and K. Ekroos High-throughput molecular lipidomics Lipidomics 2012 Wiley-VCH Verlag GmbH & Co. KGaA 35 51
87. M. Stahlman, B. Fagerberg, M. Adiels, K. Ekroos, J.M. Chapman, and A. Kontush et al. Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles Biochim Biophys Acta 1831 2013 1609 1617
88. M. Stahlman, H.T. Pham, M. Adiels, T.W. Mitchell, S.J. Blanksby, and B. Fagerberg et al. Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes Diabetologia 55 2012 1156 1166
89. C. Stegemann, I. Drozdov, J. Shalhoub, J. Humphries, C. Ladroue, and A. Didangelos et al. Comparative lipidomics profiling of human atherosclerotic plaques/clinical perspective Circ Cardiovasc Genet 4 2011 232 242
90. H.R. Superko Advanced lipoprotein testing and subfractionation are clinically useful Circulation 119 2009 2383 2395
91. M. Sysi-Aho, J. Koikkalainen, T. Seppanen-Laakso, M. Kaartinen, J. Kuusisto, and K. Peuhkurinen et al. Serum lipidomics meets cardiac magnetic resonance imaging: profiling of subjects at risk of dilated cardiomyopathy PLoS ONE 6 2011 e15744
92. A.K. Thukkani, J. McHowat, F.-F. Hsu, M.-L. Brennan, S.L. Hazen, and D.A. Ford Identification of α-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions Circulation 108 2003 3128 3133 (Pubitemid 38031803)
93. J. Wang, A. Stancakova, P. Soininen, A.J. Kangas, J. Paananen, and J. Kuusisto et al. Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men J Intern Med 272 2012 562 572
94. H. Wei, C. Hu, M. Wang, A.M. van den Hoek, T.H. Reijmers, and S. Wopereis et al. Lipidomics reveals multiple pathway effects of a multi-components preparation on lipid biochemistry in ApoE*3Leiden.CETP mice PLoS One 7 2012 e30332
95. J.M. Weir, G. Wong, C.K. Barlow, M.A. Greeve, A. Kowalczyk, and L. Almasy et al. Plasma lipid profiling in a large population-based cohort J Lipid Res 54 2013 2898 2908
96. G. Wong, C.K. Barlow, J.M. Weir, J.B. Jowett, D.J. Magliano, and P. Zimmet et al. Inclusion of plasma lipid species improves classification of individuals at risk of type 2 diabetes PLoS ONE 8 2013 e76577
97. P. Wurtz, J.R. Raiko, C.G. Magnussen, P. Soininen, A.J. Kangas, and T. Tynkkynen et al. High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis European Heart Journal 33 2012 2307 2316
98. L. Yetukuri, I. Huopaniemi, A. Koivuniemi, M. Maranghi, A. Hiukka, and H. Nygren et al. High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy PLoS ONE 6 2011 e23589
99. A. Zerrad-Saadi, P. Therond, S. Chantepie, M. Couturier, K.A. Rye, and M.J. Chapman et al. HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis Arterioscler Thromb Vasc Biol 29 2009 2169 2175
100. C. Zhu, Q.-l Liang, P. Hu, Y.-m Wang, and G.-a Luo Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy Talanta 85 2011 1711 1720
101. A.M. Zivkovic, M.M. Wiest, U.T. Nguyen, R. Davis, S.M. Watkins, and J.B. German Effects of sample handling and storage on quantitative lipid analysis in human serum Metabolomics 5 2009 507 516